| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| P50 | author | Inge Bernstein | Q67837730 |
| Jukka-Pekka Mecklin | Q20252267 | ||
| Hans Vasen | Q51123729 | ||
| Lone Sunde | Q51628358 | ||
| Juul T Wijnen | Q55486718 | ||
| P2093 | author name string | Henry T Lynch | |
| Heikki J Järvinen | |||
| Patrice Watson | |||
| Torben Myrhøj | |||
| Markku Aarnio | |||
| P2860 | cites work | Risk of gastric cancer in hereditary nonpolyposis colorectal cancer in Korea | Q57216053 |
| Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer) Diagnostics | Q57741862 | ||
| Extracolonic cancer in hereditary nonpolyposis colorectal cancer | Q70557907 | ||
| The potential role of serum CA 125 in an ultrasound-based screening program for familial ovarian cancer | Q72361866 | ||
| Male breast cancer in the hereditary nonpolyposis colorectal cancer syndrome | Q77333259 | ||
| What's the trouble with cytology? | Q79329925 | ||
| Cancer risk in mutation carriers of DNA-mismatch-repair genes | Q34502900 | ||
| Is surveillance of the small bowel indicated for Lynch syndrome families? | Q35954134 | ||
| Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review | Q36604730 | ||
| Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer). | Q36746989 | ||
| Hereditary non-polyposis colorectal cancer: current risks of colorectal cancer largely overestimated. | Q42920853 | ||
| Is breast cancer part of the tumor spectrum of hereditary nonpolyposis colorectal cancer? | Q43006441 | ||
| MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families. | Q43604312 | ||
| The risk of brain tumours in hereditary non-polyposis colorectal cancer (HNPCC). | Q49119128 | ||
| Cancer risk in young women at risk of hereditary nonpolyposis colorectal cancer: implications for gynecologic surveillance | Q50672676 | ||
| Genotype-phenotype comparison of German MLH1 and MSH2 mutation carriers clinically affected with Lynch syndrome: a report by the German HNPCC Consortium | Q51935195 | ||
| Germ line mutations of mismatch repair genes in hereditary nonpolyposis colorectal cancer patients with small bowel cancer: International Society for Gastrointestinal Hereditary Tumours Collaborative Study | Q53254701 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 444-449 | |
| P577 | publication date | 2008-07-01 | |
| P1433 | published in | International Journal of Cancer | Q332492 |
| P1476 | title | The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome | |
| P478 | volume | 123 |
| Q57802927 | A framework to build capacity for a reflex-testing program for Lynch syndrome |
| Q33683102 | A genetic model for gallbladder carcinogenesis and its dissemination |
| Q33648552 | A molecular inversion probe-based next-generation sequencing panel to detect germline mutations in Chinese early-onset colorectal cancer patients |
| Q37089839 | A novel deleterious c.2656G>T MSH2 germline mutation in a Pakistani family with a phenotypic overlap of hereditary breast and ovarian cancer and Lynch syndrome |
| Q45936434 | A patient with four metachronous cancers and multiple adenomatous colon polyps harboring the American Founder Lynch syndrome mutation: a case report. |
| Q51331719 | A proportion of hereditary upper urinary tract urothelial carcinomas are misclassified as sporadic according to a multi-institutional database analysis: proposal of patient-specific risk identification tool |
| Q58574407 | A retrospective study of extracolonic, non-endometrial cancer in Swedish Lynch syndrome families |
| Q37838462 | A systematic review of gynecological cancer surveillance in women belonging to hereditary nonpolyposis colorectal cancer (Lynch syndrome) families |
| Q36416282 | ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes |
| Q83172998 | Adrenocortical carcinoma, an unusual extracolonic tumor associated with Lynch II syndrome |
| Q30426125 | Advances in the genetics of glioblastoma: are we reaching critical mass? |
| Q51759825 | Alcohol consumption and early-onset risk of colorectal cancer in Japanese patients with Lynch syndrome: a cross-sectional study conducted by the Japanese Society for Cancer of the Colon and Rectum |
| Q48246873 | Anaplastic oligodendroglioma in an adolescent with Lynch syndrome. |
| Q35469854 | Applying public health screening criteria: how does universal newborn screening compare to universal tumor screening for Lynch syndrome in adults with colorectal cancer? |
| Q39042915 | Approach to Lynch Syndrome for the Gastroenterologist. |
| Q84030213 | Atypical identification of Lynch syndrome by immunohistochemistry and microsatellite instability analysis on jejunal adenocarcinoma |
| Q37114675 | Biomarker in Colorectal Cancer. |
| Q34161642 | Breast cancer susceptibility: current knowledge and implications for genetic counselling |
| Q36245422 | Breast carcinoma and Lynch syndrome: molecular analysis of tumors arising in mutation carriers, non-carriers, and sporadic cases |
| Q34910918 | Cancer Genetics: Risks and Mechanisms of Cancer in Women with Inherited Susceptibility to Epithelial Ovarian Cancer |
| Q38100658 | Cancer risk in Lynch Syndrome |
| Q33582756 | Cancer risk in MLH1, MSH2 and MSH6 mutation carriers; different risk profiles may influence clinical management |
| Q50556962 | Cancer risks and immunohistochemical profiles linked to the Danish MLH1 Lynch syndrome founder mutation. |
| Q92134834 | Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database |
| Q39198359 | Cancer screening behaviors and risk perceptions among family members of colorectal cancer patients with unexplained mismatch repair deficiency |
| Q84347151 | Causes of death of mutation carriers in Finnish Lynch syndrome families |
| Q35019094 | Cervical neuroendocrine tumor in a young female with Lynch Syndrome |
| Q90410559 | Challenges in the identification of inherited risk of ovarian cancer: where should we go from here? |
| Q87092782 | Changes in Specialists’ Perspectives on Cancer Genetic Testing, Prophylactic Surgery and Insurance Discrimination: Then and Now |
| Q38929029 | Changing patterns of referrals and outcomes of genetic participation in gynaecological-oncology multidisciplinary care |
| Q62978086 | Characteristics of Lynch syndrome associated ovarian cancer |
| Q90729302 | Clinical Factors Associated with Urinary Tract Cancer in Individuals with Lynch Syndrome |
| Q26749157 | Clinical Genetic Testing in Gastroenterology |
| Q92403143 | Clinical characteristics of patients with colorectal cancer with double somatic mismatch repair mutations compared with Lynch syndrome |
| Q38100643 | Clinical importance of Familial Pancreatic Cancer Registry in Japan: a report from kick-off meeting at International Symposium on Pancreas Cancer 2012. |
| Q35954814 | Clinicopathological Features and Management of Cancers in Lynch Syndrome |
| Q34174654 | Clinicopathological and genetic features of Chinese hereditary nonpolyposis colorectal cancer (HNPCC). |
| Q55924124 | Colorectal cancer |
| Q35318672 | Combined colonoscopy and endometrial biopsy cancer screening results in women with Lynch syndrome |
| Q35474031 | Comparative effectiveness of screening strategies for Lynch syndrome. |
| Q30587310 | Comparing universal Lynch syndrome tumor-screening programs to evaluate associations between implementation strategies and patient follow-through |
| Q91895870 | Comparison of screening strategies for Lynch syndrome in patients with newly diagnosed endometrial cancer: a prospective cohort study in China |
| Q64238410 | Comprehensive Paired Tumor/Germline Testing for Lynch Syndrome: Bringing Resolution to the Diagnostic Process |
| Q35991337 | Creation of a network to promote universal screening for Lynch syndrome: the LynchSyndrome Screening Network |
| Q34639739 | Current advance in small bowel tumors |
| Q21328691 | Current hypotheses on how microsatellite instability leads to enhanced survival of Lynch Syndrome patients |
| Q35211661 | Decisions about prophylactic gynecologic surgery: a qualitative study of the experience of female Lynch syndrome mutation carriers |
| Q26796491 | Deficient mismatch repair: Read all about it (Review) |
| Q52673450 | Desmoplastic Tumor Microenvironment and Immunotherapy in Cholangiocarcinoma. |
| Q37797761 | Diagnosing Hereditary Colorectal Cancer |
| Q34610509 | Diagnosis and management of hereditary colorectal cancer syndromes: Lynch syndrome as a model |
| Q46585107 | Dietary patterns and colorectal adenomas in Lynch syndrome: the GEOLynch cohort study |
| Q47756509 | Discordant Mismatch Repair Protein Immunoreactivity in Lynch Syndrome-Associated Neoplasms: A Recommendation for Screening Synchronous/Metachronous Neoplasms |
| Q34507528 | Distinct gene expression profiles in ovarian cancer linked to Lynch syndrome |
| Q50742113 | Distinct molecular profiles in Lynch syndrome-associated and sporadic ovarian carcinomas |
| Q104739130 | Double somatic mismatch repair gene pathogenic variants as common as Lynch syndrome among endometrial cancer patients |
| Q24655053 | EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome |
| Q26865704 | Early detection and prevention of pancreatic cancer: is it really possible today? |
| Q60302084 | Endometrial Carcinoma, Grossing and Processing Issues: Recommendations of the International Society of Gynecologic Pathologists |
| Q36178261 | Endometrial and Ovarian Cancer in Lynch Syndrome |
| Q37288004 | Endometrial and ovarian cancer in women with Lynch syndrome: update in screening and prevention |
| Q28303873 | Endometrial cancer and Lynch syndrome: clinical and pathologic considerations |
| Q83133097 | Endometrial cancers and predisposition |
| Q40804249 | Equivalent Helicobacter pylori infection rates in Lynch syndrome mutation carriers with and without a first-degree relative with gastric cancer |
| Q34514962 | Estimating penetrance from multiple case families with predisposing mutations: extension of the 'genotype-restricted likelihood' (GRL) method |
| Q44719816 | Excess of extracolonic non-endometrial multiple primary cancers in MSH2 germline mutation carriers over MLH1. |
| Q30453984 | Extracolonic Manifestations of Lynch Syndrome |
| Q38467435 | Familial colorectal cancer |
| Q34265940 | Features of ovarian cancer in Lynch syndrome (Review). |
| Q44117163 | First degree relatives and familial aggregation of gastric cancer: who to choose for control in case-control studies? |
| Q35038381 | First reported case of a squamous cell carcinoma arising in the duodenum in a patient with Lynch syndrome |
| Q38062023 | Follow-up recommendations and risk-reduction initiatives for Lynch syndrome |
| Q38934067 | Gastric carcinoma in canines and humans, a review. |
| Q37921953 | Gastric tumours in hereditary cancer syndromes: clinical features, molecular biology and strategies for prevention |
| Q35885813 | Gender-Specific Aspects of Lynch Syndrome and Familial Adenomatous Polyposis |
| Q90321477 | Genetic Counseling and Surveillance Focused on Lynch Syndrome |
| Q37798758 | Genetic counseling considerations in the evaluation of families for Lynch syndrome--a review |
| Q37468316 | Genetic risk and gynecologic cancers. |
| Q53137270 | Genetic testing for Lynch syndrome in the province of Ontario. |
| Q51219045 | Genetics of gastric cancer. |
| Q38211737 | Genetics, biomarkers, hereditary cancer syndrome diagnosis, heterogeneity and treatment: a review |
| Q28394400 | Germline rearrangements in families with strong family history of glioma and malignant melanoma, colon, and breast cancer |
| Q34481263 | Germline truncating-mutations in BRCA1 and MSH6 in a patient with early onset endometrial cancer |
| Q27691826 | Glioblastoma genetics: in rapid flux |
| Q39558666 | Glioblastoma multiforme as initial internal malignancy in Muir-Torre syndrome (MTS). |
| Q48345663 | Glioblastomas, astrocytomas and oligodendrogliomas linked to Lynch syndrome |
| Q51063696 | Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-society Task Force on colorectal cancer |
| Q83769643 | HNPCC (hereditary non-polyposis colorectal cancer) or Lynch syndrome: a syndrome related to a failure of DNA repair system |
| Q37221783 | Health benefits and cost-effectiveness of primary genetic screening for Lynch syndrome in the general population. |
| Q37910384 | Hereditary Colon Cancer Syndromes |
| Q38061384 | Hereditary Renal Tumor Syndromes: Imaging Findings and Management Strategies |
| Q36990149 | Hereditary cancer registries improve the care of patients with a genetic predisposition to cancer: contributions from the Dutch Lynch syndrome registry |
| Q38241489 | Hereditary cancer syndromes with high risk of endometrial and ovarian cancer: surgical options for personalized care |
| Q33918280 | Hereditary colon cancer: lynch syndrome |
| Q34648373 | Hereditary nonpolyposis colorectal cancer (HNPCC)/Lynch syndrome |
| Q34480707 | Hereditary ovarian cancer: not only BRCA 1 and 2 genes. |
| Q34977063 | Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management |
| Q30249161 | High risk factors of pancreatic carcinoma. |
| Q37968220 | Identification of Individuals at Risk for Lynch Syndrome Using Targeted Evaluations and Genetic Testing: National Society of Genetic Counselors and the Collaborative Group of the Americas on Inherited Colorectal Cancer Joint Practice Guideline |
| Q55058657 | Identification of a novel MSH6 germline variant in a family with multiple gastro-intestinal malignancies by next generation sequencing. |
| Q35179173 | Immunohistochemical analysis of mismatch repair proteins in Iranian colorectal cancer patients at risk for lynch syndrome |
| Q92461421 | Immunotherapy in colorectal cancer: rationale, challenges and potential |
| Q37146388 | Implementing screening for Lynch syndrome among patients with newly diagnosed colorectal cancer: summary of a public health/clinical collaborative meeting |
| Q26772272 | Implications of mismatch repair-deficient status on management of early stage colorectal cancer |
| Q90529965 | Importance of gastric cancer for the diagnosis and surveillance of Japanese Lynch syndrome patients |
| Q48249964 | Increasing awareness and knowledge of lifestyle recommendations for cancer prevention in Lynch syndrome carriers: Randomized controlled trial. |
| Q38006385 | Inherited Risk of Ovarian Cancer and the Implications for Screening |
| Q35000971 | Integrated analysis of mismatch repair system in malignant astrocytomas. |
| Q37073180 | Intraductal papillary mucinous neoplasm of the pancreas with loss of mismatch repair in a patient with Lynch syndrome |
| Q91879304 | Investigating the Link between Lynch Syndrome and Breast Cancer |
| Q37073606 | Is it all Lynch syndrome?: An assessment of family history in individuals with mismatch repair-deficient tumors |
| Q91852820 | Lynch Syndrome in Urologic Malignancies - What Does the Urologist Need to Know? |
| Q35821477 | Lynch Syndrome in patients with clear cell and endometrioid cancers of the ovary |
| Q37994931 | Lynch or Not Lynch? Is that Always a Question? |
| Q26797255 | Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer |
| Q28067471 | Lynch syndrome and exposure to aristolochic acid in upper-tract urothelial carcinoma: its clinical impact? |
| Q47630690 | Lynch syndrome and sextuple primary malignancies. |
| Q36758454 | Lynch syndrome related endometrial cancer: clinical significance beyond the endometrium |
| Q37987828 | Lynch syndrome: clinical, pathological, and genetic insights |
| Q37430836 | Management of extracolonic tumours in patients with Lynch syndrome |
| Q34988799 | Management of ovarian and endometrial cancers in women belonging to HNPCC carrier families: review of the literature and results of cancer risk assessment in Polish HNPCC families |
| Q30426539 | Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portu |
| Q57698678 | Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portug |
| Q36958508 | Metastatic colorectal carcinoma mimicking primary ovarian carcinoma presenting as ‘giant’ ovarian tumors in an individual with probable Lynch syndrome: a case report |
| Q45152203 | Microsatellite Instability andTARBP2Mutation Study in Upper Urinary Tract Urothelial Carcinoma |
| Q90284677 | Microsatellite Instability in Endometrial Carcinoma by Immunohistochemistry, Association with Clinical and Histopathologic Parameters |
| Q24627393 | Microsatellite instability in colorectal cancer |
| Q83835402 | Microsatellite instability in colorectal cancer: from molecular oncogenic mechanisms to clinical implications |
| Q36124008 | Microsatellite instability testing and its role in the management of colorectal cancer. |
| Q43864989 | Milestones of Lynch syndrome: 1895-2015. |
| Q29248750 | Mismatch Repair Polymorphisms as Markers of Breast Cancer Prevalence in the Breast Cancer Family Registry |
| Q38741029 | Mismatch repair deficiency testing in clinical practice |
| Q26747329 | Molecular Subtypes and Personalized Therapy in Metastatic Colorectal Cancer |
| Q37710556 | Molecular Testing for Gastrointestinal Cancer. |
| Q26764919 | Molecular alterations in gastric cancer with special reference to the early-onset subtype |
| Q41343102 | Molecular analysis of Iranian colorectal cancer patients at risk for Lynch syndrome: a new molecular, clinicopathological feature |
| Q50055151 | Molecular classification and precision therapy of cancer: immune checkpoint inhibitors |
| Q88783378 | Molecular subtype classification of urothelial carcinoma in Lynch syndrome |
| Q38732720 | Müllerian intra-abdominal carcinomatosis in hereditary breast ovarian cancer syndrome: implications for risk-reducing surgery |
| Q37830205 | Newer developments in the therapeutics of the transitional cell carcinoma of renal pelvis |
| Q35744898 | Novel germline MSH2 mutation in lynch syndrome patient surviving multiple cancers |
| Q27315851 | Observational Study: Familial Relevance and Oncological Significance of Revised Bethesda Guidelines in Colorectal Patients That Have Undergone Curative Resection |
| Q37390074 | Occult transitional cell carcinoma and Lynch syndrome incidentally revealed after laparoscopic hysterectomy and cystoscopy during staging for endometrial cancer |
| Q45068704 | Ovarian Cancer Prevention in High-risk Women |
| Q83572257 | Ovarian cancer linked to Lynch syndrome typically presents as early-onset, non-serous epithelial tumors |
| Q38143316 | Ovarian cancer: risk factors, treatment and management |
| Q27024662 | PMS2 monoallelic mutation carriers: the known unknown |
| Q47153954 | Pancreatic Cancer in Lynch Syndrome Patients |
| Q36182997 | Pancreatic cancer and a novel MSH2 germline alteration |
| Q90565268 | Pathologic findings and clinical outcomes in women undergoing risk-reducing surgery to prevent ovarian and fallopian tube carcinoma: A large prospective single institution experience |
| Q37693658 | Pathological features and clinical behavior of Lynch syndrome-associated ovarian cancer. |
| Q62002182 | Pathophysiology of Hereditary Diffuse Gastric Cancer |
| Q49551587 | Patient communication of cancer genetic test results in a diverse population |
| Q46324177 | Phenotypic and genotypic heterogeneity of Lynch syndrome: a complex diagnostic challenge |
| Q43625600 | Phenotypic heterogeneity of hereditary gynecologic cancers: a report from the Creighton hereditary cancer registry |
| Q47745633 | Prevalence and prognostic role of mismatch repair gene defect in endometrial cancer patients |
| Q34600647 | Primary peritoneal cancer after bilateral salpingo-oophorectomy in two patients with Lynch syndrome |
| Q42378389 | Profiling cancer-associated genetic alterations and molecular classification of cancer in Korean gastric cancer patients. |
| Q37834463 | Prophylactic surgery in Lynch syndrome |
| Q34459728 | Prospective study of combined colon and endometrial cancer screening in women with lynch syndrome: a patient-centered approach |
| Q36219067 | Pseudomyxoma peritonei of a mature ovarian teratoma caused by mismatch repair deficiency in a patient with Lynch syndrome: a case report |
| Q51743129 | Recognizing Gynecological Cancer in Primary Care: Risk Factors, Red Flags, and Referrals. |
| Q44080353 | Recurrence and variability of germline EPCAM deletions in Lynch syndrome. |
| Q40516598 | Reproductive Decision-Making in MMR Mutation Carriers After Results Disclosure: Impact of Psychological Status in Childbearing Options. |
| Q90210420 | Resolving gastric cancer aetiology: an update in genetic predisposition |
| Q24610838 | Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications |
| Q36824964 | Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts |
| Q36758605 | Risk assessment, genetic testing, and management of Lynch syndrome |
| Q36903207 | Risk of breast cancer in Lynch syndrome: a systematic review. |
| Q36897112 | Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study |
| Q34163849 | Risk of endometrial cancer for women diagnosed with HNPCC-related colorectal carcinoma |
| Q33880380 | Risk of pancreatic cancer in families with Lynch syndrome |
| Q34346668 | Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers |
| Q37996440 | Role of common genetic variants in ovarian cancer susceptibility and outcome: progress to date from the Ovarian Cancer Association Consortium (OCAC). |
| Q83159492 | Sarcomas associated with hereditary nonpolyposis colorectal cancer: broad anatomical and morphological spectrum |
| Q37071737 | Screening adherence and cancer risk perceptions in colorectal cancer survivors with Lynch-like syndrome. |
| Q48107196 | Screening for Lynch syndrome using risk assessment criteria in patients with ovarian cancer. |
| Q33715019 | Screening of the DNA mismatch repair genes MLH1, MSH2 and MSH6 in a Greek cohort of Lynch syndrome suspected families |
| Q53251543 | Strategies for screening for pancreatic adenocarcinoma in high-risk patients: the place of endoscopic ultrasound |
| Q48219440 | Suggestion of added value by bevacizumab to chemotherapy in patients with unresectable or recurrent small bowel cancer. |
| Q38108741 | Surveillance for urinary tract cancer in Lynch syndrome. |
| Q36205603 | Synchronous and metachronous malignancy in endometrial cancer patients treated in a tertiary care center of Thailand |
| Q58568666 | Synchronous endometrial and ovarian cancer in Lynch syndrome with a germline mutation: A case report |
| Q34121605 | Synchronous gastric and sebaceous cancers, a rare manifestation of MLH1-related Muir-Torre syndrome |
| Q64934285 | Systematic Review: An Update on the Spectrum of Urological Malignancies in Lynch Syndrome. |
| Q36210453 | TP53 Polymorphisms and Colorectal Cancer Risk in Patients with Lynch Syndrome in Taiwan: A Retrospective Cohort Study |
| Q36245933 | Targeted DNA Sequencing Detects Mutations Related to Susceptibility among Familial Non-medullary Thyroid Cancer |
| Q48483117 | Teenage colorectal polyposis and cancer may be caused by constitutional mismatch repair deficiency (CMMRD). |
| Q37058193 | The double-edged sword of ovarian cancer information for women at increased risk who have previously taken part in screening |
| Q34081267 | The genetic basis of Lynch syndrome and its implications for clinical practice and risk management |
| Q38789406 | The genetic prediction of risk for gynecologic cancers. |
| Q34775177 | The inherited genetics of ovarian and endometrial cancer |
| Q59548976 | The results of gynecologic surveillance in families with hereditary nonpolyposis colorectal cancer |
| Q37524923 | The risk of colorectal cancer is not increased after a diagnosis of urothelial cancer: a population-based study |
| Q43970731 | The spectrum of urological malignancy in Lynch syndrome |
| Q83830781 | Thirty-Nine-Year-Old With Familial Colon Cancer, and Variant of Undetermined Significance in MSH6 |
| Q38979257 | Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care |
| Q47729288 | Towards gene- and gender-based risk estimates in Lynch syndrome; age-specific incidences for 13 extra-colorectal cancer types |
| Q52577954 | Tumor development in Japanese patients with Lynch syndrome |
| Q37731657 | Two cases of successful pregnancies after hysteroscopic removal of endometrioid adenocarcinoma grade I, stage IA, in young women with Lynch syndrome |
| Q38737901 | Understanding the Pathogenicity of Noncoding Mismatch Repair Gene Promoter Variants in Lynch Syndrome |
| Q93345706 | Universal tumor screening for Lynch syndrome: perspectives of Canadian pathologists and genetic counselors |
| Q36990046 | Update on Lynch syndrome genomics |
| Q43662370 | Upper Urinary Tract Carcinoma in Lynch Syndrome Cases |
| Q51421660 | Upper tract urothelial carcinomas: frequency of association with mismatch repair protein loss and lynch syndrome |
| Q34604182 | Ureteroscopic management of upper tract urothelial carcinoma (UTUC) in patients with Lynch Syndrome (hereditary nonpolyposis colorectal cancer syndrome) |
| Q41345672 | Urinary Tract Cancer in Lynch Syndrome; Increased Risk in Carriers of MSH2 Mutations. |
| Q51020589 | Urinary tract cancer in patients with hereditary non-polyposis colorectal cancer |
| Q59272977 | Uroepithelial and kidney carcinoma in Lynch syndrome |
Search more.